We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

75 hedge funds and large institutions have $335M invested in Abeona Therapeutics in 2017 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

544% more call options, than puts

Call options by funds: $27.1M | Put options by funds: $4.21M

239% more capital invested

Capital invested by funds: $98.6M → $335M (+$236M)

93% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 15

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

7% more funds holding

Funds holding: 70 → 75 (+5)

0.42% more ownership

Funds ownership: 1.53% → 1.95% (+0.42%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
75
Holders Change
+5
Holders Change %
+7.14%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
29
Reduced
15
Closed
11
Calls
$27.1M
Puts
$4.21M
Net Calls
+$22.9M
Net Calls Change
+$19M

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$24.1M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.4M
3
CHP
Castle Hook Partners
New York
+$4.35M
4
BlackRock
BlackRock
New York
+$4.18M
5
PC
PointState Capital
New York
+$4.06M

Top Sellers

Rank Fund Capital Flow
1
SFM
Soros Fund Management
New York
-$5.74M
2
HCM
Highbridge Capital Management
New York
-$4.27M
3
NC
Nexthera Capital
New York
-$3.81M
4
PA
Perceptive Advisors
New York
-$3.29M
5
JGC
J. Goldman & Co
New York
-$3.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$40.2M – – –
Viking Global Investors
2
Viking Global Investors
Connecticut
$38.2M +$24.1M +89,549 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$34.1M +$536K +1,996 +3%
BBA
4
Baker Bros. Advisors
New York
$28.7M – – –
BlackRock
5
BlackRock
New York
$27.7M +$4.18M +15,557 +32%
Citadel Advisors
6
Citadel Advisors
Florida
$24.5M +$15.4M +57,453 New
CHP
7
Castle Hook Partners
New York
$23.4M +$4.35M +16,195 +42%
Vanguard Group
8
Vanguard Group
Pennsylvania
$17.3M -$697K -2,592 -6%
HCM
9
Highbridge Capital Management
New York
$8.53M -$4.27M -15,908 -44%
CAM
10
Cormorant Asset Management
Massachusetts
$6.82M – – –
PC
11
PointState Capital
New York
$6.45M +$4.06M +15,120 New
State Street
12
State Street
Massachusetts
$5.76M +$443K +1,648 +14%
KAM
13
Kavi Asset Management
New York
$4.44M -$1.13M -4,208 -29%
Northern Trust
14
Northern Trust
Illinois
$4.39M -$3.23K -12 -0.1%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.25M +$182K +678 +7%
Deutsche Bank
16
Deutsche Bank
Germany
$4.21M +$2.36M +8,764 +786%
Millennium Management
17
Millennium Management
New York
$4.05M +$2.55M +9,501 New
RA
18
Royce & Associates
New York
$3.87M -$914K -3,400 -27%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$3.56M +$2.25M +8,359 New
Wellington Management Group
20
Wellington Management Group
Massachusetts
$3.54M +$184K +686 +9%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$3.53M +$2.22M +8,274 New
Barclays
22
Barclays
United Kingdom
$3.44M +$2.16M +8,036 +19,133%
EI
23
EAM Investors
California
$2.51M +$1.58M +5,887 New
Goldman Sachs
24
Goldman Sachs
New York
$2.45M +$1.43M +5,321 +1,255%
UBS Group
25
UBS Group
Switzerland
$2.06M +$1.28M +4,780 +7,710%
1
2 3 4

ABEO Hedge Fund Activity: Q3 2017 in Review

75 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2017, worth a combined $335M — up 239% from $98.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ABEO positions and 11 closed out — a net gain of 5 holders — while 29 added to existing stakes and 15 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $24.1M. The largest seller was Soros Fund Management, exiting entirely with an estimated $5.74M sold.

  • 75 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2017, up from 70 in Q2 2017.
  • Funds reported $335M of Abeona Therapeutics stock for Q3 2017, up 239% quarter-over-quarter.
  • 16 funds opened new Abeona Therapeutics positions in Q3 2017 and 11 closed out, a net change of +5 holders.
  • The largest Abeona Therapeutics buyer in Q3 2017 was Viking Global Investors, an estimated $24.1M added.
  • The largest Abeona Therapeutics seller in Q3 2017 was Soros Fund Management, an estimated $5.74M sold.

Based on aggregated 13F filings for Q3 2017.